Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-09

Clinical Trial Update: A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing olopatadine and fluticasone in allergic conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone (fluticasone propionate)
  • OLOPATADINE (OLOPATADINE)

Snippet

Sponsor: Greiner, Jack V., OD DO PhD | Conditions: Conjunctivitis, Allergic | Phase 4 | Status: COMPLETED